RPL22 and psoriasis: To explore the critical role of RPL22 upregulation in the development of psoriasis in vivo, we established IMQ induced psoriasis-like mouse model and simultaneously injected with OE-RPL22 or si-RPL22 intradermally daily for the first three consecutive days (0/1/2/3 day).